Observational studyCNS neuroscience & therapeutics2026

Double-Filtration Plasmapheresis Versus Efgartigimod for Generalized Myasthenia Gravis: Severity-Stratified Benefits in a Prospective Observational Multicenter Study.

Kan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.